Biomark Diagnostics Inc. (FRA:20B)
0.2600
+0.0120 (4.84%)
Last updated: Dec 19, 2025, 8:01 AM CET
Biomark Diagnostics Market Cap
Biomark Diagnostics has a market cap or net worth of €27.32 million as of December 22, 2025. Its market cap has increased by 144.42% in one year.
Market Cap
27.32M
Enterprise Value
26.87M
Revenue
75.52K
Ranking
n/a
PE Ratio
n/a
Stock Price
€0.26
Market Cap Chart
Since November 27, 2014, Biomark Diagnostics's market cap has decreased from 28.50M to 27.32M, a decrease of -4.11%. That is a compound annual growth rate of -0.38%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 19, 2025 | 27.32M | 175.81% |
| Dec 30, 2024 | 9.91M | -19.08% |
| Dec 29, 2023 | 12.24M | 23.53% |
| Dec 30, 2022 | 9.91M | -23.89% |
| Dec 30, 2021 | 13.02M | 134.71% |
| Dec 30, 2020 | 5.55M | -54.32% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SAP SE | 243.17B |
| Siemens Aktiengesellschaft | 183.57B |
| Allianz SE | 146.73B |
| Deutsche Telekom AG | 129.76B |
| Siemens Energy AG | 102.30B |
| Rheinmetall AG | 71.12B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 70.51B |
| Deutsche Bank Aktiengesellschaft | 62.30B |